Connection
Mark Manzano to Dengue Virus
This is a "connection" page, showing publications Mark Manzano has written about Dengue Virus.
|
|
Connection Strength |
|
|
|
|
|
1.675 |
|
|
|
-
Manzano M, Padmanabhan R. Targeted mutagenesis of dengue virus type 2 replicon RNA by yeast in vivo recombination. Methods Mol Biol. 2014; 1138:151-60.
Score: 0.466
-
Manzano M, Padia J, Padmanabhan R. Small molecule inhibitor discovery for dengue virus protease using high-throughput screening. Methods Mol Biol. 2014; 1138:331-44.
Score: 0.466
-
Manzano M, Reichert ED, Polo S, Falgout B, Kasprzak W, Shapiro BA, Padmanabhan R. Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication. J Biol Chem. 2011 Jun 24; 286(25):22521-34.
Score: 0.387
-
Boonyasuppayakorn S, Reichert ED, Manzano M, Nagarajan K, Padmanabhan R. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res. 2014 Jun; 106:125-34.
Score: 0.118
-
Teramoto T, Chiang HS, Takhampunya R, Manzano M, Padmanabhan R, Maric M. Gamma interferon-inducible lysosomal thioreductase (GILT) ablation renders mouse fibroblasts sensitive to dengue virus replication. Virology. 2013 Jul 05; 441(2):146-51.
Score: 0.111
-
Alcaraz-Estrada SL, Manzano MI, Del Angel RM, Levis R, Padmanabhan R. Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5. J Gen Virol. 2010 Nov; 91(Pt 11):2713-8.
Score: 0.092
-
Balasubramanian A, Manzano M, Teramoto T, Pilankatta R, Padmanabhan R. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Res. 2016 10; 134:6-16.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|